Blood Group Typing Market by Product (Consumable (Anti-sera), Instrument, Service), Test Type (ABO, Antigen, Antibody Screening, Cross Matching, HLA), Technique (Assay, PCR, Microarray, Massively Parallel Sequencing), End User - Global Forecast to 2021

血液型判定の世界市場予測(~2021年):消耗品、装置、サービス

◆タイトル:Blood Group Typing Market by Product (Consumable (Anti-sera), Instrument, Service), Test Type (ABO, Antigen, Antibody Screening, Cross Matching, HLA), Technique (Assay, PCR, Microarray, Massively Parallel Sequencing), End User - Global Forecast to 2021
◆商品コード:MAM-MD5210
◆調査・発行会社:MarketsandMarkets
◆発行日:2017年4月28日
◆ページ数:140
◆レポート形式:PDF / 英語
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名利用)USD5,650 ⇒換算¥638,450見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥751,450見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥920,950見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarketsの日本における正規販売代理店です。

【レポートの概要】

当調査レポートでは、血液型判定の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、製品別分析、試験種類別分析、技術別分析、需要先別分析、血液型判定の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。

The blood group typing market is projected to reach USD 3.12 Billion by 2021 from USD 1.95 Billion in 2016, at a CAGR of 9.8%. The increasing demand for blood and blood products, growing number of road accidents and trauma cases that necessitate blood transfusion, need for blood grouping during prenatal testing, and increasing usage of blood group typing in forensic sciences are the major factors fueling the growth of this market.
The blood group typing market is segmented based on product & service, technique, test type, end user, and region. On the basis of product & service, the market is segmented into consumables, instruments, and services. The consumables segment is further categorized into antisera reagents, anti-human globulin reagents, red blood cells reagents, and blood bank saline. The consumables segment is expected to grow at the highest CAGR during the forecast period. The increase in blood donation rates and major surgical procedures (including organ transplant procedures) are the key factors driving the growth of this segment.

By technique, the market is classified into PCR-based and microarray techniques, assay-based techniques, massively parallel sequencing, and other techniques. The PCR-based and microarray techniques segment is expected to grow at the highest CAGR during the forecast period. The large share and high growth of this segment can be attributed to the rising prevalence of chronic diseases and increasing R&D activities focused on understanding the molecular basis of blood and antibody-antigen interactions.

By test type, the market is classified into antibody screening, HLA typing, cross-matching tests, ABO blood tests, and antigen typing. The antibody screening segment is expected to grow at the highest CAGR during the forecast period. The growth of this market segment is primarily driven by the increasing prevalence of chronic disorders and growing demand for the early diagnosis of diseases.

Based on end user, the market is classified into hospitals, blood banks, clinical laboratories, and other end users. The hospitals end-user segment is expected to grow at the highest CAGR during the forecast period. This growth can be attributed to the increasing awareness on blood donations and their importance, rising number of blood donations, and growing requirement of blood in surgical treatments.

The market is segmented into four major regions North America, Europe, Asia, and the Rest of the World. In 2016, North America accounted for the largest share of the market, followed by Europe. North America will continue to dominate the market in the forecast period due to the availability of reimbursement for several surgeries and increasing prevalence of chronic disorders in the region. However, the market in Asia is expected to witness the highest CAGR, with the growth centered on China, Japan, and India.

Key players in the market include Bio-Rad Laboratories, Inc. (U.S.), Grifols, S.A. (Spain), Immucor, Inc. (U.S.), Ortho Clinical Diagnostics, Inc. (U.S.), Quotient, Ltd. (U.S.), Novacyt Group (France), BAG Healthcare GmbH (Germany), Rapid Labs (U.K.), Day medical SA (Switzerland), DIAGAST (France), and AXO Science (France).

【レポートの目次】

1 Introduction (Page No. – 16)
1.1 Objectives of the Study
1.2 Market Definition
1.2.1 Markets Covered
1.2.2 Years Considered for the Study
1.3 Currency
1.4 Limitations
1.5 Stakeholders

2 Research Methodology (Page No. – 19)
2.1 Secondary Data
2.1.1 Key Data From Secondary Sources
2.2 Primary Data
2.2.1 Key Data From Primary Sources
2.3 Market Size Estimation
2.3.1 Bottom-Up Approach
2.3.2 Top-Down Approach
2.4 Market Breakdown and Data Triangulation
2.5 Assumptions for the Study

3 Executive Summary (Page No. – 27)

4 Premium Insights (Page No. – 31)
4.1 Blood Group Typing: Market Overview
4.2 Geographic Analysis: Blood Group Typing Market, By End User (2016)
4.3 Geographical Snapshot of the Blood Group Typing Market
4.4 Blood Group Typing Market Size, By Technique, 2016 vs 2021

5 Market Overview (Page No. – 34)
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Increasing Number of Blood Donations
5.2.1.2 Growing Number of Road Accidents, Emergencies, and Trauma Cases Necessitating Blood Transfusions
5.2.1.3 Increasing Demand for Blood Group Typing in Prenatal Testing
5.2.1.4 Increasing Usage of Blood Group Typing in Forensic Sciences
5.2.1.5 Stringent Regulatory Standards for Blood Transfusion Will Fuel Market Growth
5.2.2 Opportunities
5.2.2.1 Emerging Economies
5.2.2.2 Blood Group Typing With Molecular Diagnostics

6 Blood Group Typing Market, By Product and Service (Page No. – 41)
6.1 Introduction
6.2 Consumables
6.2.1 Antisera Reagents
6.2.2 Red Blood Cell Reagents
6.2.3 Anti-Human Globulin Reagents
6.2.4 Blood Bank Saline
6.3 Instruments
6.4 Services

7 Blood Group Typing Market, By Technique (Page No. – 48)
7.1 Introduction
7.2 PCR-Based and Microarray Techniques
7.3 Assay-Based Techniques
7.4 Massively Parallel Sequencing
7.5 Other Techniques

8 Blood Group Typing Market, By Test Type (Page No. – 54)
8.1 Introduction
8.2 Antibody Screening
8.3 HLA Typing
8.4 ABO Blood Tests
8.5 Cross-Matching Tests
8.6 Antigen Typing

9 Blood Group Typing Market, By End User (Page No. – 61)
9.1 Introduction
9.2 Hospitals
9.3 Clinical Laboratories
9.4 Blood Banks
9.5 Other End Users

10 Blood Group Typing Market, By Region (Page No. – 67)
10.1 Introduction
10.2 North America
10.2.1 U.S.
10.2.2 Canada
10.3 Europe
10.3.1 Germany
10.3.2 U.K.
10.3.3 France
10.3.4 RoE
10.4 Asia
10.5 Rest of the World

11 Competitive Landscape (Page No. – 95)
11.1 Introduction
11.2 Vendor Dive Overview
11.2.1 Vanguards
11.2.2 Innovator
11.2.3 Dynamic
11.2.4 Emerging
11.3 Competitive Benchmarking
11.3.1 Product Offerings (For All 25 Players)
11.3.2 Business Strategy (For All 25 Players)

12 Company Profiles (Page No. – 99)
12.1 Bio-Rad Laboratories, Inc.
12.1.1 Overview
12.1.2 Products Offered
12.1.3 Company Scorecard
12.1.3.1 Product Offerings
12.1.3.2 Business Strategy
12.1.4 Recent Developments (2014-2017)
12.2 Beckman Coulter (A Subsidiary of Danaher)
12.2.1 Overview
12.2.2 Products Offered
12.2.3 Company Scorecard
12.2.3.1 Product Offerings
12.2.3.2 Business Strategy
12.2.4 Recent Developments (2014-2017)
12.3 Grifols International, S.A.
12.3.1 Overview
12.3.2 Products Offered
12.3.3 Company Scorecard
12.3.3.1 Product Offerings
12.3.3.2 Business Strategy
12.3.4 Recent Developments (2014-2017)
12.4 Immucor, Inc.
12.4.1 Overview
12.4.2 Products Offered
12.4.3 Company Scorecard
12.4.3.1 Product Offerings
12.4.3.2 Business Strategy
12.4.4 Recent Developments (2014-2017)
12.5 Merck KGaA
12.5.1 Overview
12.5.2 Products Offered
12.5.3 Company Scorecard
12.5.3.1 Product Offerings
12.5.3.2 Business Strategy
12.5.4 Recent Developments (2014–2017)
12.6 Novacyt Group
12.6.1 Overview
12.6.2 Products Offered
12.6.3 Company Scorecard
12.6.3.1 Product Offerings
12.6.3.2 Business Strategy
12.6.4 Recent Developments (2014–2017)
12.7 Quotient, Ltd.
12.7.1 Overview
12.7.2 Products Offered
12.7.3 Company Scorecard
12.7.3.1 Product Offerings
12.7.3.2 Business Strategy
12.7.4 Recent Developments (2014-2017)
12.8 Ortho Clinical Diagnostics, Inc.
12.8.1 Overview
12.8.2 Products Offered
12.8.3 Company Scorecard
12.8.3.1 Product Offerings
12.8.3.2 Business Strategy
12.8.4 Recent Developments (2014-2017)
12.9 Bag Health Care GmbH
12.9.1 Overview
12.9.2 Products Offered
12.9.3 Company Scorecard
12.9.3.1 Product Offerings
12.9.3.2 Business Strategy
12.9.4 Recent Developments (2014-2017)
12.10 Rapid Labs
12.10.1 Overview
12.10.2 Products Offered
12.10.3 Company Scorecard
12.10.3.1 Product Offerings
12.10.3.2 Business Strategy
12.10.4 Recent Developments (2014-2017)
12.11 AXO Science
12.11.1 Overview
12.11.2 Products Offered
12.11.3 Company Scorecard
12.11.3.1 Product Offerings
12.11.3.2 Business Strategy
12.11.4 Recent Developments (2014-2017)
12.12 Agena Bioscience, Inc.
12.12.1 Overview
12.12.2 Products Offered
12.12.3 Company Scorecard
12.12.3.1 Product Offerings
12.12.3.2 Business Strategy
12.12.4 Recent Developments (2014-2017)
12.13 Day Medical SA
12.13.1 Overview
12.13.2 Products Offered
12.13.3 Company Scorecard
12.13.3.1 Product Offerings
12.13.3.2 Business Strategy
12.13.4 Recent Developments (2014-2017)

13 Appendix (Page No. – 140)
13.1 Insights of Industry Experts
13.2 Discussion Guide
13.3 Knowledge Store: Marketsandmarkets’ Subscription Portal
13.4 Introducing RT: Real-Time Market Intelligence
13.5 Available Customizations
13.6 Related Reports

List of Tables (68 Tables)

Table 1 Market Size, By Product and Service, 2014–2021 (USD Million)
Table 2 Blood Group Typing Consumables Market Size, By Type, 2014-2021 (USD Million)
Table 3 Blood Group Typing Consumables Market Size, By Region, 2014–2021 (USD Million)
Table 4 Antisera Reagents Market Size, By Region, 2014–2021 (USD Million)
Table 5 Red Blood Cell Reagents Market Size, By Region, 2014–2021 (USD Million)
Table 6 Anti-Human Globulin Reagents Market Size, By Region, 2014–2021 (USD Million)
Table 7 Blood Bank Saline Market Size, By Region, 2014–2021 (USD Million)
Table 8 Blood Group Typing Instruments Market Size, By Region, 2014–2021 (USD Million)
Table 9 Market Size for Services, By Region, 2014–2021 (USD Million)
Table 10 Market Size, By Technique, 2014–2021 (USD Million)
Table 11 Market Size for PCR-Based and Microarray Techniques, By Region, 2014–2021 (USD Million)
Table 12 Market Size for Assay-Based Techniques, By Region, 2014–2021 (USD Million)
Table 13 Market Size for Massively Parallel Sequencing, By Region, 2014–2021 (USD Million)
Table 14 Market Size for Other Techniques, By Region, 2014–2021 (USD Million)
Table 15 Market Size, By Test Type, 2014–2021 (USD Million)
Table 16 Market Size for Antibody Screening, By Region, 2014–2021 (USD Million)
Table 17 Market Size for HLA Typing, By Region, 2014–2021 (USD Million)
Table 18 Market Size for ABO Blood Tests, By Region, 2014–2021 (USD Million)
Table 19 Blood Typing Market Size for Cross-Matching Tests, By Region, 2014–2021 (USD Million)
Table 20 Blood Group Typing Market Size for Antigen Typing, By Region, 2014–2021 (USD Million)
Table 21 Global Market Size, By End User, 2014–2021 (USD Million)
Table 22 Global Market Size for Hospitals, By Region, 2014–2021 (USD Million)
Table 23 Global Market Size for Clinical Laboratories, By Region, 2014–2021 (USD Million)
Table 24 Global Market Size for Blood Banks, By Region, 2014–2021 (USD Million)
Table 25 Global Market Size for Other End Users, By Region, 2014–2021 (USD Million)
Table 26 Blood Group Typing Market Size, By Region, 2014–2021 (USD Million)
Table 27 North America: Market Size, By Product & Service, 2014–2021 (USD Million)
Table 28 North America: Market Size, By Technique, 2014–2021 (USD Million)
Table 29 North America: Market Size, By Test Type, 2014–2021 (USD Million)
Table 30 North America: Market Size, By End User, 2014–2021 (USD Million)
Table 31 North America: Market Size, By Country, 2014–2021 (USD Million)
Table 32 U.S.: Market Size, By Product & Service, 2014–2021 (USD Million)
Table 33 U.S.: Market Size, By Technique, 2014–2021 (USD Million)
Table 34 U.S.: Market Size, By Test Type, 2014–2021 (USD Million)
Table 35 U.S.: Market Size, By End User, 2014–2021 (USD Million)
Table 36 Canada: Market Size, By Product & Service, 2014–2021 (USD Million)
Table 37 Canada: Market Size, By Technique, 2014–2021 (USD Million)
Table 38 Canada: Market Size, By Test Type, 2014–2021 (USD Million)
Table 39 Canada: Market Size, By End User, 2014–2021 (USD Million)
Table 40 Europe: Market Size, By Product & Service, 2014–2021 (USD Million)
Table 41 Europe: Market Size, By Technique, 2014–2021 (USD Million)
Table 42 Europe: Market Size, By Test Type, 2014–2021 (USD Million)
Table 43 Europe: Market Size, By End User, 2014–2021 (USD Million)
Table 44 Europe: Market Size, By Country, 2014–2021 (USD Million)
Table 45 Germany: Market Size, By Product & Service, 2014–2021 (USD Million)
Table 46 Germany: Market Size, By Technique, 2014–2021 (USD Million)
Table 47 Germany: Market Size, By Test Type, 2014–2021 (USD Million)
Table 48 Germany: Market Size, By End User, 2014–2021 (USD Million)
Table 49 U.K.: Market Size, By Product & Service, 2014–2021 (USD Million)
Table 50 U.K.: Market Size, By Technique, 2014–2021 (USD Million)
Table 51 U.K.: Market Size, By Test Type, 2014–2021 (USD Million)
Table 52 U.K.: Market Size, By End User, 2014–2021 (USD Million)
Table 53 France: Market Size, By Product & Service, 2014–2021 (USD Million)
Table 54 France : Market Size, By Technique, 2014–2021 (USD Million)
Table 55 France: Market Size, By Test Type, 2014–2021 (USD Million)
Table 56 France: Market Size, By End User, 2014–2021 (USD Million)
Table 57 RoE: Market Size, By Product & Service, 2014–2021 (USD Million)
Table 58 RoE: Market Size, By Technique, 2014–2021 (USD Million)
Table 59 RoE: Market Size, By Test Type, 2014–2021 (USD Million)
Table 60 RoE: Market Size, By End User, 2014–2021 (USD Million)
Table 61 Asia: Market Size, By Product & Service, 2014–2021 (USD Million)
Table 62 Asia: Market Size, By Technique, 2014–2021 (USD Million)
Table 63 Asia: Market Size, By Test Type, 2014–2021 (USD Million)
Table 64 Asia: Market Size, By End User, 2014–2021 (USD Million)
Table 65 RoW: Market Size, By Product & Service, 2014–2021 (USD Million)
Table 66 RoW: Market Size, By Technique, 2014–2021 (USD Million)
Table 67 RoW: Market Size, By Test Type, 2014–2021 (USD Million)
Table 68 RoW: Market Size, By End User, 2014–2021 (USD Million)

List of Figures (69 Figures)

Figure 1 Global Blood Group Typing Market
Figure 2 Research Design
Figure 3 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 4 Blood Group Typing Market: Bottom-Up Approach
Figure 5 Blood Group Typing Market: Top-Down Approach
Figure 6 Data Triangulation Methodology
Figure 7 Global Blood Group Typing Market Size, By Product & Service, 2016 vs 2021 (USD Million)
Figure 8 Blood Group Typing Market Size, By Technique, 2016 vs 2021 (USD Million)
Figure 9 Blood Group Typing Market Size, By Test Type, 2016 vs 2021 (USD Million)
Figure 10 Global Blood Group Typing Market Size, By End User, 2016 vs 2021 (USD Million)
Figure 11 Geographic Snapshot of the Global Blood Group Typing Market
Figure 12 Global Blood Group Typing Market to Witness Moderate Growth During the Forecast Period
Figure 13 Hospitals Accounted for the Largest Share of the Global Blood Group Typing Market in 2016
Figure 14 Asia to Register the Highest Growth Rate During the Forecast Period
Figure 15 PCR-Based and Microarray Segment Will Continue to Dominate the Blood Group Typing Market in 2021
Figure 16 Blood Group Typing Market: Drivers, Opportunities, and Trends
Figure 17 Consumables Segment Will Continue to Dominate Blood Group Typing Market, By Product, in 2021
Figure 18 PCR-Based and Microarray Techniques Segment to Dominate the Blood Group Typing Market in 2016
Figure 19 Blood Group Typing Market, By Test Type
Figure 20 U.S.: Total Organ Transplants, 2014 vs 2015
Figure 21 Hospitals, the Largest End-User Segment in 2016
Figure 22 Regional Snapshot: Emerging Markets in Asia Offer Significant Growth Opportunities
Figure 23 Blood Group Typing Market, By Region (Market Size and Growth Rate), 2016–2021
Figure 24 North America: Blood Group Typing Market Snapshot
Figure 25 PCR-Based and Microarray Formed the Largest Techniques Segment in the North American Market in 2016
Figure 26 Antibody Screening Tests Dominated the U.S. Blood Group Typing Market in 2016
Figure 27 Hospitals Dominated Blood Group Typing Market, By End User, in Canada (2016)
Figure 28 Antibody Screening Was the Largest Test Type Segment in the European Market in 2016
Figure 29 Hospitals Was the Largest End-User Segment in the Market in Germany (2016)
Figure 30 PCR-Based and Microarray—The Largest Techniques Segment in the U.K. Market in 2016
Figure 31 Consumables: the Largest Product Type Segment in the Market in France
Figure 32 Antibody Screening Was the Largest Test Type Segment in the RoE Market in 2016
Figure 33 Asia: Blood Group Typing Market Snapshot
Figure 34 Consumables Dominated the Blood Group Typing Products Market in Asia
Figure 35 Antibody Screening Formed the Largest Test Segment in the RoW Market in 2016
Figure 36 Dive Chart
Figure 37 Bio-Rad Laboratories, Inc: Company Snapshot (2015)
Figure 38 Bio-Rad Laboratories, Inc: Product Offering Scorecard
Figure 39 Bio-Rad Laboratories, Inc: Business Strategy Scorecard
Figure 40 Danaher Corporation: Company Snapshot (2016)
Figure 41 Danaher Corporation: Product Offering Scorecard
Figure 42 Danaher Corporation: Business Strategy Scorecard
Figure 43 Grifols International, S.A.: Company Snapshot (2016)
Figure 44 Grifols International, S.A.: Product Offering Scorecard
Figure 45 Grifols International, S.A.: Business Strategy Scorecard
Figure 46 Immucor, Inc.: Company Snapshot (2016)
Figure 47 Immucor, Inc.: Product Offering Scorecard
Figure 48 Immucor, Inc.: Business Strategy Scorecard
Figure 49 Merck KGaA: Company Snapshot (2016)
Figure 50 Merck KGaA: Product Offering Scorecard
Figure 51 Merck KGaA: Business Strategy Scorecard
Figure 52 Novacyt Group: Company Snapshot (2015)
Figure 53 Novacyt Group: Product Offering Scorecard
Figure 54 Novacyt Group: Business Strategy Scorecard
Figure 55 Quotient, Ltd.: Company Snapshot (2016)
Figure 56 Quotient, Ltd.: Product Offering Scorecard
Figure 57 Quotient, Ltd.: Business Strategy Scorecard
Figure 58 Ortho Clinical Diagnostics, Inc.: Product Offering Scorecard
Figure 59 Ortho Clinical Diagnostics, Inc.: Business Strategy Scorecard
Figure 60 Bag Health Care GmbH: Product Offering Scorecard
Figure 61 Bag Health Care GmbH: Business Strategy Scorecard
Figure 62 Rapid Labs: Product Offering Scorecard
Figure 63 Rapid Labs: Business Strategy Scorecard
Figure 64 AXO Science: Product Offering Scorecard
Figure 65 AXO Science: Business Strategy Scorecard
Figure 66 Agena Bioscience: Product Offering Scorecard
Figure 67 Agena Bioscience: Business Strategy Scorecard
Figure 68 Day Medical SA: Product Offering Scorecard
Figure 69 Day Medical SA: Business Strategy Scorecard



【レポートのキーワード】

血液型判定、血液型判定試験、消耗品、血液型判定装置、血液型判定サービス、血液型検査

★調査レポート[血液型判定の世界市場予測(~2021年):消耗品、装置、サービス] ( Blood Group Typing Market by Product (Consumable (Anti-sera), Instrument, Service), Test Type (ABO, Antigen, Antibody Screening, Cross Matching, HLA), Technique (Assay, PCR, Microarray, Massively Parallel Sequencing), End User - Global Forecast to 2021 / MAM-MD5210) 販売に関する免責事項
[血液型判定の世界市場予測(~2021年):消耗品、装置、サービス] ( Blood Group Typing Market by Product (Consumable (Anti-sera), Instrument, Service), Test Type (ABO, Antigen, Antibody Screening, Cross Matching, HLA), Technique (Assay, PCR, Microarray, Massively Parallel Sequencing), End User - Global Forecast to 2021 / MAM-MD5210) についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆